Clinical Trial

A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of ONO-3310 in healthy Japanese adult male subjects and chronic kidney disease patients with type 2 diabetes mellitus
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-09
Trial Details
NCT Number NCT07619157
Lead Sponsor Ono Pharmaceutical Co., Ltd.
Conditions Type2 Diabetes Mellitus, Chronic Kidney Disease
Enrollment 120 participants
Start Date 2026-06-02
Primary Completion 2027-11-30 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-08